Myriad Genetics Sells Prenatal Health Testing Business to LabCorp
2 reports, 2 independent
Updated Nov 1
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Myriad Genetics announced it is selling its Prenatal Health testing business to LabCorp. The transaction includes tests such as Prequel®, Foresight®, SneakPeek®, and FirstGene®. LabCorp will acquire the business for $210 million in cash, plus the value of the inventory.
From manilatimes.net
Why it matters
The sale is expected to be accretive to Myriad Genetics’ revenue growth and profitability while strengthening its balance sheet. The transaction is also expected to provide more patients and physicians with expanded access to LabCorp’s services.
From manilatimes.net
Who's involved
- Myriad GeneticsSeller of the Prenatal Health testing business
- LabCorpBuyer of the Prenatal Health testing business
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.- Labcorp's acquisition of Myriad may increase pressure on Applied DNA SciencesLabCorp's expanded diagnostic capacity may increase competitive pressure on Applied DNA SciencesPossible
- LabCorp's prenatal testing acquisition may challenge Quest DiagnosticsQuest Diagnostics may face increased competition from LabCorp's expanded prenatal testing portfolio.Possible
- Labcorp's new prenatal testing services may require FDA oversightLabcorp's expanded prenatal testing portfolio may require FDA reviewPossible
- Labcorp's prenatal testing acquisition may increase Medicare utilizationIncreased prenatal testing volume could expand Medicare's utilization of lab services.Possible
Keep exploring
The entities involved
-
Myriad Genetics
American biotechnology company
Nothing else this week.
-
LabCorp
clinical laboratory company
Nothing else this week.